This clinical trial studies how well inspiratory muscle training (IMT) and aerobic exercise training work together in reducing exercise intolerance in obese breast cancer survivors. When exercise capacity is reduced due to cancer and metabolic demand is higher due to obesity, further limitations to activity can occur and distressing exertional symptoms can lead to sedentariness and loss of quality of life. Further, impaired breathing mechanics and suboptimal inspiratory muscle functioning could contribute to exercise intolerance and dyspnea in obese patients, which results in reduced engagement in habitual exercise. This study seeks to understand why some breast cancer survivors have difficulty exercising and to determine if a program that strengthens the breathing muscles can help make it easier to tolerate exercise.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05193149.
Locations matching your search criteria
United States
Ohio
Columbus
Ohio State University Comprehensive Cancer CenterStatus: Active
Contact: Dharini M Bhammar
Phone: 614-366-9467
PRIMARY OBJECTIVE:
I. Determine the effects of IMT on breathing mechanics and exercise tolerance in obese breast cancer survivors.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants undergo supervised and home-based/virtually supervised IMT sessions using the POWERbreathe Classic training device for 3 sets of 15 repetitions over 30 minutes per session three times a week (TIW) for 4 weeks and complete supervised aerobic exercise training sessions over 50 minutes per session TIW for 12 weeks.
ARM II: Participants undergo supervised and home-based/virtually supervised sham sessions using the POWERbreathe Classic training device for 3 sets of 15 repetitions over 30 minutes per session TIW for 4 weeks and complete supervised aerobic exercise training sessions over 50 minutes per session TIW for 12 weeks.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationOhio State University Comprehensive Cancer Center
Principal InvestigatorDharini M Bhammar